サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：集団健康管理の世界市場：成長、将来展望、競合分析 (2022年～2030年)
市場調査レポート
商品コード
1176027

集団健康管理の世界市場：成長、将来展望、競合分析 (2022年～2030年)

Population Health Management Market - Growth, Future Prospects and Competitive Analysis, 2022 - 2030
出版日: | 発行: Acute Market Reports | ページ情報: 英文 118 Pages | 納期: 即日から翌営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.65円
集団健康管理の世界市場：成長、将来展望、競合分析 (2022年～2030年)
出版日: 2022年08月08日
発行: Acute Market Reports
ページ情報: 英文 118 Pages
納期: 即日から翌営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の集団健康管理 (PHM) の市場規模は、2017年の210億7,990万米ドルから、2026年までに815億3,980万米ドルに達する見込みであり、予測期間中 (2018年～2026年) に16.3%のCAGRで目覚ましい成長を遂げると予測されています。

製品別では、医療サービスのセグメントが市場を支配しています。近年では有料サービスから価値ベースの医療提供へのパラダイムシフトが顕著であり、それが医療サービスの市場成長を促進しています。またソフトウェアのセグメントも、統合型医療システムの需要増大により、安定したペースで成長します。

エンドユーザー別では、医療提供者のセグメントが市場を支配しています。洗練された臨床結果で優れた疾患管理を実行する医療提供者の能力は、一般の人々の間で人気を博しており、医療費を大幅に削減し、患者中心型ケアに専念することに成功しています。一方で支払者のセグメントも、構造化されていない臨床転帰と、人口動向を解釈しながら分析能力を予測する能力により、急速に成長しつつあります。

地域別では、北米が最大のセグメントです。主に慢性疾患の有病率の上昇により、36%のシェアを占めています。欧州は、集団健康管理に関連するプロバイダーの数が大幅に増加したため、32%の市場シェアで2番目の位置を占めています。アジア太平洋は、医療インフラの改善と1人あたりの所得の増加により、21%のシェアを占めています。

当レポートでは、世界の集団健康管理市場について分析し、市場の基本構造やマクロ的・ミクロ的環境要因、全体的な市場規模の動向見通し (2020年～2030年)、製品別・エンドユーザー別および地域別の詳細動向、主な市場促進・抑制要因、主要企業のプロファイルと成長戦略、新型コロナウイルス感染症 (COVID-19) の影響、といった情報を取りまとめてお届けいたします。

目次

第1章 序文

第2章 エグゼクティブサマリー

第3章 集団健康管理市場：ビジネスの展望と市場力学

  • イントロダクション
  • 世界の集団健康管理の市場規模 (単位：100万米ドル、2020年～2030年)
  • 市場力学
    • 市場促進要因
    • 市場抑制要因
    • 主な課題
    • 主な機会
  • 促進・抑制要因の影響分析
  • シーソー分析
  • ポーターのファイブフォース分析
  • PESTEL分析

第4章 集団健康管理市場：製品別 (単位：100万米ドル、2020年～2030年)

  • 市場概要
  • 成長・収益分析 (2021年/2030年)
  • 市場区分
    • ソフトウェア
    • サービス

第5章 集団健康管理市場：エンドユーザー別 (単位：100万米ドル、2020年～2030年)

  • 市場概要
  • 成長・収益分析 (2021年/2030年)
  • 市場区分
    • 医療提供者
    • 支払者
    • 雇用者団体

第6章 北米の集団健康管理市場 (単位：100万米ドル、2020年～2030年)

  • 市場概要
  • 集団健康管理市場：製品別 (単位：100万米ドル、2020年～2030年)
  • 集団健康管理市場：エンドユーザー別 (単位：100万米ドル、2020年～2030年)
  • 集団健康管理市場：地域別 (単位：100万米ドル、2020年～2030年)
    • 北米
  • 市場概要
  • 人口健康管理市場：製品別、2020-2030年、米ドル (百万)
  • 人口健康管理市場：エンドユーザー別、2020年から2030年、米ドル (百万)
  • 人口健康管理市場：地域別、2020-2030年、USD (百万)
    • 北米

第7章 英国・EU諸国の集団健康管理市場 (単位：100万米ドル、2020年～2030年)

第8章 アジア太平洋の集団健康管理市場 (単位：100万米ドル、2020年～2030年)

第9章 ラテンアメリカの集団健康管理市場 (単位：100万米ドル、2020年～2030年)

第10章 中東・アフリカの集団健康管理市場 (単位：100万米ドル、2020年～2030年)

第11章 企業プロファイル

  • Cerner Corporation
  • Healthagen LLC
  • Health Catalyst
  • IBM Corporation
  • Koninklijke Philips N.V.
  • Lumeris
  • McKesson Corporation
  • Persivia, Inc.
  • ZeOmega
  • UnitedHealth Group.
図表

List of Tables

  • TABLE 1 Global Population Health Management Market By Product, 2020-2030, USD (Million)
  • TABLE 2 Global Population Health Management Market By End User, 2020-2030, USD (Million)
  • TABLE 3 North America Population Health Management Market By Product, 2020-2030, USD (Million)
  • TABLE 4 North America Population Health Management Market By End User, 2020-2030, USD (Million)
  • TABLE 5 UK and European Union Population Health Management Market By Product, 2020-2030, USD (Million)
  • TABLE 6 UK and European Union Population Health Management Market By End User, 2020-2030, USD (Million)
  • TABLE 7 Asia Pacific Population Health Management Market By Product, 2020-2030, USD (Million)
  • TABLE 8 Asia Pacific Population Health Management Market By End User, 2020-2030, USD (Million)
  • TABLE 9 Latin America Population Health Management Market By Product, 2020-2030, USD (Million)
  • TABLE 10 Latin America Population Health Management Market By End User, 2020-2030, USD (Million)
  • TABLE 11 Middle East and Africa Population Health Management Market By Product, 2020-2030, USD (Million)
  • TABLE 12 Middle East and Africa Population Health Management Market By End User, 2020-2030, USD (Million)

List of Figures

  • FIG. 1 Global Population Health Management Market: Market Coverage
  • FIG. 2 Research Methodology and Data Sources
  • FIG. 3 Market Size Estimation - Top Down & Bottom-Up Approach
  • FIG. 4 Global Population Health Management Market: Quality Assurance
  • FIG. 5 Global Population Health Management Market, By Product, 2021
  • FIG. 6 Global Population Health Management Market, By End User, 2021
  • FIG. 7 Global Population Health Management Market, By Geography, 2021
  • FIG. 8 Global Population Health Management Market, By Product, 2021 Vs 2030, %
  • FIG. 9 Global Population Health Management Market, By End User, 2021 Vs 2030, %
  • FIG. 10 U.S. Population Health Management Market (US$ Million), 2020 - 2030
  • FIG. 11 Canada Population Health Management Market (US$ Million), 2020 - 2030
  • FIG. 12 Rest of North America Population Health Management Market (US$ Million), 2020 - 2030
  • FIG. 13 UK Population Health Management Market (US$ Million), 2020 - 2030
  • FIG. 14 Germany Population Health Management Market (US$ Million), 2020 - 2030
  • FIG. 15 Spain Population Health Management Market (US$ Million), 2020 - 2030
  • FIG. 16 Italy Population Health Management Market (US$ Million), 2020 - 2030
  • FIG. 17 France Population Health Management Market (US$ Million), 2020 - 2030
  • FIG. 18 Rest of Europe Population Health Management Market (US$ Million), 2020 - 2030
  • FIG. 19 China Population Health Management Market (US$ Million), 2020 - 2030
  • FIG. 20 Japan Population Health Management Market (US$ Million), 2020 - 2030
  • FIG. 21 India Population Health Management Market (US$ Million), 2020 - 2030
  • FIG. 22 Australia Population Health Management Market (US$ Million), 2020 - 2030
  • FIG. 23 South Korea Population Health Management Market (US$ Million), 2020 - 2030
  • FIG. 24 Rest of Asia Population Health Management Market (US$ Million), 2020 - 2030
  • FIG. 25 Brazil Population Health Management Market (US$ Million), 2020 - 2030
  • FIG. 26 Mexico Population Health Management Market (US$ Million), 2020 - 2030
  • FIG. 27 Rest of Latin America Population Health Management Market (US$ Million), 2020 - 2030
  • FIG. 28 GCC Population Health Management Market (US$ Million), 2020 - 2030
  • FIG. 29 Africa Population Health Management Market (US$ Million), 2020 - 2030
  • FIG. 30 Rest of Middle East and Africa Population Health Management Market (US$ Million), 2020 - 2030
目次
Product Code: 138690-08-22

Industry Outlook

The population health management (PHM) market is set to reach US$ 81,539.8 Mn by 2026 from US$ 21,079.9 Mn in 2017 projecting impressive growth at a compounded annual growth rate (CAGR) of 16.3% during the forecast period from 2018 to 2026. PHM solutions are capable to perform tedious task associated with financial, clinical and operational data to refine workflow and patient care. Software companies worldwide are providing services pertaining to management of chronic illness and reduction in healthcare cost.

Paradigm shift from paid service to value based healthcare delivery drives the healthcare services market growth

Healthcare services are dominating the product segment for population health management market. The recent trend observed in healthcare highlights a paradigm shift from paid service to value based healthcare delivery which drives the healthcare service providers market growth. They are highly employed by hospitals to create an in-house system to assess their patient data rather than involving third parties. The software segment will grow at a steady pace owing to the increasing demand for integrated healthcare system. Ability to manage multiple business activity on a single platform and precise analysis of patient data in a well-managed network will propel the software market in the near future.

Excellent disease management with refined clinical outcomes increases the demand for healthcare providers

In the current scenario healthcare providers are reigning the end user segment for population health management market. The ability of healthcare providers to perform excellent disease management with refined clinical outcomes has led to its popularity among general public. It has been successful in drastically reducing healthcare cost and focus on patient centric care. Payers are insurance providers which are actively engaged in providing reimbursement for the cost incurred during treatment. The ability to predict analytical competency while interpreting unstructured clinical outcomes and population behavior will propel the healthcare payers market growth at a faster pace.

Enhanced government funding to provide financial support to healthcare segment and rising prevalence of chronic disease together drive the market growth in North America

North America is the largest regional segment for population health management market. It occupies 36% share primarily due to rising prevalence of chronic disease. As per research findings of Center for Disease Control and Prevention (CDC), approximately 130 million U.S. citizens are suffering with some form of chronic ailment. The government is expected to spend 4.8 trillion dollars in the healthcare segment by 2021 which represents 20% of the gross domestic product (GDP). Europe holds second position with 32% market share owing to significant rise in the number of providers pertaining to population healthcare. Asia Pacific represents 21% share on account of improving healthcare infrastructure and rise in per capita income. It serves as a lucrative market opportunity for major players to cater healthcare benefits to ailing patient population.

Software companies providing services pertaining to population health management are: Cerner Corporation, Healthagen LLC, Health Catalyst, IBM Corporation, Koninklijke Philips N.V., Lumeris, McKesson Corporation, Persivia, Inc., ZeOmega, UnitedHealth Group.

Historical & Forecast Period

This study report represents analysis of each segment from 2020 to 2030 considering 2021 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2022 to 2030.

The current report comprises of quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends and technological analysis, case studies, strategic conclusions and recommendations and other key market insights.

Research Methodology

The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. key data point that enables the estimation of Population Health Management market are as follows:

  • Research and development budgets of manufacturers and government spending
  • Revenues of key companies in the market segment
  • Number of end users and consumption volume, price and value.

Geographical revenues generate by countries considered in the report:

Micro and macro environment factors that are currently influencing the Population Health Management market and their expected impact during the forecast period.

Market forecast was performed through proprietary software that analyzes various qualitative and quantitative factors. Growth rate and CAGR were estimated through intensive secondary and primary research. Data triangulation across various data points provides accuracy across various analyzed market segments in the report. Application of both top down and bottom-up approach for validation of market estimation assures logical, methodical and mathematical consistency of the quantitative data.

Market Segmentation

Product

  • Software
  • Services

End User

  • Providers
  • Payers
  • Employer Groups

Region Segment (2020-2030; US$ Million)

  • North America
    • U.S.
    • Canada
    • Rest of North America
  • UK and European Union
    • UK
    • Germany
    • Spain
    • Italy
    • France
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East and Africa
    • GCC
    • Africa
    • Rest of Middle East and Africa

Global Impact of COVID-19 Segment (2020-2021; US$ Million )

  • Pre COVID-19 situation
  • Post COVID-19 situation

Key questions answered in this report:

  • What are the key micro and macro environmental factors that are impacting the growth of Population Health Management market?
  • What are the key investment pockets with respect to product segments and geographies currently and during the forecast period?
  • Estimated forecast and market projections up to 2030.
  • Which segment accounts for the fastest CAGR during the forecast period?
  • Which market segment holds a larger market share and why?
  • Are low and middle-income economies investing in the Population Health Management market?
  • Which is the largest regional market for Population Health Management market?
  • What are the market trends and dynamics in emerging markets such as Asia Pacific, Latin America, and Middle East & Africa?
  • Which are the key trends driving Population Health Management market growth?
  • Who are the key competitors and what are their key strategies to enhance their market presence in the Population Health Management market worldwide?

Table of Contents

1. Preface

  • 1.1. Report Description
    • 1.1.1. Purpose of the Report
    • 1.1.2. Target Audience
    • 1.1.3. Key Offerings
  • 1.2. Market Segmentation
  • 1.3. Research Methodology
    • 1.3.1. Phase I - Secondary Research
    • 1.3.2. Phase II - Primary Research
    • 1.3.3. Phase III - Expert Panel Review
    • 1.3.4. Assumptions
    • 1.3.5. Approach Adopted

2. Executive Summary

  • 2.1. Market Snapshot: Global Population Health Management Market
  • 2.2. Global Population Health Management Market, By Product, 2021 (US$ Million)
  • 2.3. Global Population Health Management Market, By End User, 2021 (US$ Million)
  • 2.4. Global Population Health Management Market, By Geography, 2021 (US$ Million)
  • 2.5. Impact of Covid 19
  • 2.6. Attractive Investment Proposition by Geography, 2021
  • 2.7. Competitive Analysis
    • 2.7.1. Market Positioning of Key Population Health Management Market Vendors
    • 2.7.2. Strategies Adopted by Population Health Management Market Vendors
    • 2.7.3. Key Industry Strategies

3. Population Health Management Market: Business Outlook & Market Dynamics

  • 3.1. Introduction
  • 3.2. Global Population Health Management Market Value, 2020 - 2030, (US$ Million)
  • 3.3. Market Dynamics
    • 3.3.1. Market Drivers
    • 3.3.2. Market Restraints
    • 3.3.3. Key Challenges
    • 3.3.4. Key Opportunities
  • 3.4. Impact Analysis of Drivers and Restraints
  • 3.5. See-Saw Analysis
  • 3.6. Porter's Five Force Model
    • 3.6.1. Supplier Power
    • 3.6.2. Buyer Power
    • 3.6.3. Threat Of Substitutes
    • 3.6.4. Threat Of New Entrants
    • 3.6.5. Competitive Rivalry
  • 3.7. PESTEL Analysis
    • 3.7.1. Political Landscape
    • 3.7.2. Economic Landscape
    • 3.7.3. Technology Landscape
    • 3.7.4. Legal Landscape
    • 3.7.5. Social Landscape

4. Population Health Management Market: By Product, 2020-2030, USD (Million)

  • 4.1. Market Overview
  • 4.2. Growth & Revenue Analysis: 2021 Versus 2030
  • 4.3. Market Segmentation
    • 4.3.1. Software
    • 4.3.2. Services

5. Population Health Management Market: By End User, 2020-2030, USD (Million)

  • 5.1. Market Overview
  • 5.2. Growth & Revenue Analysis: 2021 Versus 2030
  • 5.3. Market Segmentation
    • 5.3.1. Providers
    • 5.3.2. Payers
    • 5.3.3. Employer Groups

6. North America Population Health Management Market, 2020-2030, USD (Million)

  • 6.1. Market Overview
  • 6.2. Population Health Management Market: By Product, 2020-2030, USD (Million)
  • 6.3. Population Health Management Market: By End User, 2020-2030, USD (Million)
  • 6.4.Population Health Management Market: By Region, 2020-2030, USD (Million)
    • 6.4.1.North America
      • 6.4.1.1. U.S.
      • 6.4.1.2. Canada
      • 6.4.1.3. Rest of North America

7. UK and European Union Population Health Management Market, 2020-2030, USD (Million)

  • 7.1. Market Overview
  • 7.2. Population Health Management Market: By Product, 2020-2030, USD (Million)
  • 7.3. Population Health Management Market: By End User, 2020-2030, USD (Million)
  • 7.4.Population Health Management Market: By Region, 2020-2030, USD (Million)
    • 7.4.1.UK and European Union
      • 7.4.1.1. UK
      • 7.4.1.2. Germany
      • 7.4.1.3. Spain
      • 7.4.1.4. Italy
      • 7.4.1.5. France
      • 7.4.1.6. Rest of Europe

8. Asia Pacific Population Health Management Market, 2020-2030, USD (Million)

  • 8.1. Market Overview
  • 8.2. Population Health Management Market: By Product, 2020-2030, USD (Million)
  • 8.3. Population Health Management Market: By End User, 2020-2030, USD (Million)
  • 8.4.Population Health Management Market: By Region, 2020-2030, USD (Million)
    • 8.4.1.Asia Pacific
      • 8.4.1.1. China
      • 8.4.1.2. Japan
      • 8.4.1.3. India
      • 8.4.1.4. Australia
      • 8.4.1.5. South Korea
      • 8.4.1.6. Rest of Asia Pacific

9. Latin America Population Health Management Market, 2020-2030, USD (Million)

  • 9.1. Market Overview
  • 9.2. Population Health Management Market: By Product, 2020-2030, USD (Million)
  • 9.3. Population Health Management Market: By End User, 2020-2030, USD (Million)
  • 9.4.Population Health Management Market: By Region, 2020-2030, USD (Million)
    • 9.4.1.Latin America
      • 9.4.1.1. Brazil
      • 9.4.1.2. Mexico
      • 9.4.1.3. Rest of Latin America

10. Middle East and Africa Population Health Management Market, 2020-2030, USD (Million)

  • 10.1. Market Overview
  • 10.2. Population Health Management Market: By Product, 2020-2030, USD (Million)
  • 10.3. Population Health Management Market: By End User, 2020-2030, USD (Million)
  • 10.4.Population Health Management Market: By Region, 2020-2030, USD (Million)
    • 10.4.1.Middle East and Africa
      • 10.4.1.1. GCC
      • 10.4.1.2. Africa
      • 10.4.1.3. Rest of Middle East and Africa

11. Company Profile

  • 11.1. Cerner Corporation
    • 11.1.1. Company Overview
    • 11.1.2. Financial Performance
    • 11.1.3. Product Portfolio
    • 11.1.4. Strategic Initiatives
  • 11.2. Healthagen LLC
    • 11.2.1. Company Overview
    • 11.2.2. Financial Performance
    • 11.2.3. Product Portfolio
    • 11.2.4. Strategic Initiatives
  • 11.3. Health Catalyst
    • 11.3.1. Company Overview
    • 11.3.2. Financial Performance
    • 11.3.3. Product Portfolio
    • 11.3.4. Strategic Initiatives
  • 11.4. IBM Corporation
    • 11.4.1. Company Overview
    • 11.4.2. Financial Performance
    • 11.4.3. Product Portfolio
    • 11.4.4. Strategic Initiatives
  • 11.5. Koninklijke Philips N.V.
    • 11.5.1. Company Overview
    • 11.5.2. Financial Performance
    • 11.5.3. Product Portfolio
    • 11.5.4. Strategic Initiatives
  • 11.6. Lumeris
    • 11.6.1. Company Overview
    • 11.6.2. Financial Performance
    • 11.6.3. Product Portfolio
    • 11.6.4. Strategic Initiatives
  • 11.7. McKesson Corporation
    • 11.7.1. Company Overview
    • 11.7.2. Financial Performance
    • 11.7.3. Product Portfolio
    • 11.7.4. Strategic Initiatives
  • 11.8. Persivia, Inc.
    • 11.8.1. Company Overview
    • 11.8.2. Financial Performance
    • 11.8.3. Product Portfolio
    • 11.8.4. Strategic Initiatives
  • 11.9. ZeOmega
    • 11.9.1. Company Overview
    • 11.9.2. Financial Performance
    • 11.9.3. Product Portfolio
    • 11.9.4. Strategic Initiatives
  • 11.10. UnitedHealth Group.
    • 11.10.1. Company Overview
    • 11.10.2. Financial Performance
    • 11.10.3. Product Portfolio
    • 11.10.4. Strategic Initiatives